SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Kozer E, Mordel A, Haim SB, Bulkowstein M, Berkovitch M, Bentur Y. J. Pediatr. 2005; 146(1): 41-44.

Copyright

(Copyright © 2005, Elsevier Publishing)

DOI

10.1016/j.jpeds.2004.08.056

PMID

15644820

Abstract

Objective To describe the effects of combined trimedoxime (TMB4) and atropine poisoning from automatic injectors (AI) in children. Study design Data was collected from two sources: calls to the Israel Poison Information Center (IPIC) during a 1-year period and a cohort of children who presented to pediatric emergency departments (EDs) after unintentional injection of an AI. Demographic data and data regarding the type of AI, site and time of injection, and the clinical manifestations were abstracted. Results Data were available for 142 patients. The median age was 8.5 years (range 1.25-18 years). The dose of atropine and TMB4 was higher than the recommended dose for age in 22 (15.5%) cases. There were few side effects attributable to atropine: dilated pupils (26.7%), dryness of mucous membranes (24.6%), and tachycardia (22.5%). Compared with children injected with an age-appropriate dose, children injected with an AI that contained a dose that exceeds the recommended one were more likely to be symptomatic ( P = .029). There were no side effects characteristic to oximes, and no specific medical intervention was required. Conclusions Unintentional pediatric atropine and TMB4 injection, even an adult dose in a small child, does not cause significant side effects.

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print